Peripheral artery disease is associated with severe impairment of vascular function

Vascular Medicine (United Kingdom)

Volumn 18, Issue 2, 2013, Pages 72-78

  Kiani, Soroosh ^a   Aasen, Jonathan G ^a   Holbrook, Monika ^a   Khemka, Abhishek ^a   Sharmeen, Farhana ^a   Leleiko, Rebecca M ^a   Tabit, Corey E ^a   Farber, Alik ^a   Eberhardt, Robert T ^a   Gokce, Noyan ^a   Vita, Joseph A ^a   Hamburg, Naomi M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

coronary artery disease; endothelium; peripheral artery disease; vascular testing

Indexed keywords

GLYCERYL TRINITRATE;

ADULT; AGED; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIGITAL ARTERY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPEREMIA; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PULSE RATE; TONOMETRY;

AGED; BLOOD FLOW VELOCITY; BLOOD VESSELS; BRACHIAL ARTERY; COMORBIDITY; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; NITROGLYCERIN; PERIPHERAL ARTERIAL DISEASE; VASODILATION;

EID: 84876525975     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X13480551     Document Type: Article

References (40)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Executive summary: Heart disease and stroke statistics - 2012 update: A report from the American Heart Association. Circulation. 2012 ; 125: 188-197
2. Hiatt WR.. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001 ; 344: 1608-1621 (Pubitemid 32479915)
3. Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007 ; 297: 1197-1206 (Pubitemid 46465728)
4. Vita JA, Keaney JF. Endothelial function: A barometer for cardiovascular risk?. Circulation. 2002 ; 106: 640-642 (Pubitemid 34851918)
5. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: Testing and clinical relevance. Circulation. 2007 ; 115: 1285-1295 (Pubitemid 46594773)
6. Widlansky ME, Gokce N, Keaney JF, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003 ; 42: 1149-1160 (Pubitemid 37188333)
7. Gokce N, Keaney JF, Hunter LM, et al. Predictive value of non-invasively-determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol. 2003 ; 41: 1769-1775 (Pubitemid 36584251)
8. Huang AL, Silver AE, Shvenke E, et al. Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol. 2007 ; 27: 2113-2119 (Pubitemid 350287238)
9. Gokce N, Keaney JF, Menzoian JO, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function. Circulation. 2002 ; 105: 1567-1572 (Pubitemid 34297634)
10. Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: Additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation. 2003 ; 108: 2093-2098 (Pubitemid 37337585)
11. Brevetti G, Silvestro A, Di Giacomo S, et al. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg. 2003 ; 38: 374-379 (Pubitemid 41123265)
12. McDermott MM, Ades P, Guralnik JM, et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: A randomized controlled trial. JAMA. 2009 ; 301: 165-174
13. Stokes J, Kannel WB, Wolf PA, Cupples LA, D'Agostino RB. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation. 1987 ; 75: V65 - V73
14. Pradhan AD, Shrivastava S, Cook NR, Rifai N, Creager MA, Ridker PM. Symptomatic peripheral arterial disease in women: Nontraditional biomarkers of elevated risk. Circulation. 2008 ; 117: 823-831 (Pubitemid 351640684)
15. Ho DY, Cook NR, Britton KA, et al. High-molecular-weight and total adiponectin levels and incident symptomatic peripheral artery disease in women: A prospective investigation. Circulation. 2011 ; 124: 2303-2311
16. McMackin CJ, Vita JA. Update on nitric oxide-dependent vasodilation in human subjects. Methods Enzymol. 2005 ; 396: 541-553 (Pubitemid 41603575)
17. Vita JA. Nitric oxide-dependent vasodilation in human subjects. Methods Enzymol. 2002 ; 359: 186-200 (Pubitemid 35387021)
18. Hamburg NM, Palmisano J, Larson MG, et al. Relation of brachial and digital measures of vascular function in the community: The Framingham heart study. Hypertension. 2011 ; 57: 390-396
19. Hamburg NM, Keyes MJ, Larson MG, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation. 2008 ; 117: 2467-2474 (Pubitemid 351670453)
20. Vita JA, Hamburg NM. Does endothelial dysfunction contribute to the clinical status of patients with peripheral arterial disease?. Can J Cardiol. 2010 ; 26: 45A - 50A
21. Yu HI, Sheu WH, Lai CJ, Lee WJ, Chen YT. Endothelial dysfunction in type 2 diabetes mellitus subjects with peripheral artery disease. Int J Cardiol. 2001 ; 78: 19-25 (Pubitemid 32232133)
22. Yataco AR, Corretti MC, Gardner AW, Womack CJ, Katzel LI. Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease. Am J Cardiol. 1999 ; 83: 754-758 (Pubitemid 29115450)
23. Fronek A, DiTomasso DG, Allison M. Noninvasive assessment of endothelial activity in patients with peripheral arterial disease and cardiovascular risk factors. Endothelium. 2007 ; 14: 199-205 (Pubitemid 47543005)
24. Komai H, Higami Y, Tanaka H, Honda K, Juri M, Okamura Y. Impaired flow-mediated endothelium-dependent and endothelium-independent vasodilation of the brachial artery in patients with atherosclerotic peripheral vascular disease. Angiology. 2008 ; 59: 52-56 (Pubitemid 351253080)
25. Payvandi L, Dyer A, McPherson D, et al. Physical activity during daily life and brachial artery flow-mediated dilation in peripheral arterial disease. Vasc Med. 2009 ; 14: 193-201
26. Kostic MM, Schrader J. Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ Res. 1992 ; 70: 208-212
27. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation. 1994 ; 90: 2285-2290 (Pubitemid 24354313)
28. Meredith IT, Currie KE, Anderson TJ, Roddy MA, Ganz P, Creager MA. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol. 1996 ; 270: H1435 - H1440
29. Mitchell GF, Parise H, Vita JA, et al. Local shear stress and brachial artery flow-mediated dilation: The Framingham Heart Study. Hypertension. 2004 ; 44: 134-139 (Pubitemid 39014228)
30. Vita JA, Keaney JF, Larson MG, et al. Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation. 2004 ; 110: 3604-3609 (Pubitemid 39612578)
31. Mitchell GF, Vita JA, Larson MG, et al. Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk factors, and aortic stiffness. The Framingham Heart Study. Circulation. 2005 ; 112: 3722-3728 (Pubitemid 43739512)
32. Philpott AC, Lonn E, Title LM, et al. Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factors. Am J Cardiol. 2009 ; 103: 1610-1615
33. Liao JK, Bettmann MA, Sandor T, Tucker JI, Coleman SM, Creager MA. Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis. Circ Res. 1991 ; 68: 1027-1034
34. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996 ; 27: 567-574 (Pubitemid 26081917)
35. Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mitra D, Ganz P. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol. 2006 ; 101: 545-548 (Pubitemid 44162364)
36. Hamburg NM, Benjamin EJ. Assessment of endothelial function using digital pulse amplitude tonometry. Trends Cardiovasc Med. 2009 ; 19: 6-11
37. Kuvin JT, Patel AR, Sliney KA, et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J. 2003 ; 146: 168-174 (Pubitemid 36851317)
38. Schnabel RB, Schulz A, Wild PS, et al. Noninvasive vascular function measurement in the community: Cross-sectional relations and comparison of methods. Circ Cardiovasc Imaging. 2011 ; 4: 371-380
39. Dhindsa M, Sommerlad SM, DeVan AE, et al. Interrelationships among noninvasive measures of postischemic macro- and microvascular reactivity. J Appl Physiol. 2008 ; 105: 427-432
40. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001 ; 286: 1317-1324 (Pubitemid 33015522)